Boehringer Ingelheim
Uday Bose is a seasoned pharmaceutical executive with extensive experience in oncology and customer experience excellence. At Boehringer Ingelheim from August 2014 to November 2022, Uday served as Head of Human Pharma Customer Experience Excellence and Business Steering, where responsibilities included leading the evolution of customer models and driving cross-functional activities. As Country Managing Director and Head of Human Pharma, Uday oversaw a team of over 700 employees across the UK, Ireland, Malta, and Gibraltar, managing significant P&L responsibilities. Prior to this, Uday held the position of Corporate Vice President, Head of Global Marketing in Oncology, guiding the commercial strategy for oncology products. Uday's earlier experience includes roles at Eisai as EMEA Head of Oncology Business Unit, and at GlaxoSmithKline as Marketing Director in both global and European capacities. Uday is currently pursuing a GDBA at Durham University, following an MBA in Health Economics from Keele University.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
112 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.